Total Payments
$11,145
2024 Payments
$4,026
Companies
18
Transactions
90
Medicare Patients
2,618
Medicare Billing
$220,729
Payment Breakdown by Category
Food & Beverage$6,388 (57.3%)
Other$4,000 (35.9%)
Education$757.00 (6.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,388 | 88 | 57.3% |
| Debt forgiveness | $4,000 | 1 | 35.9% |
| Education | $757.00 | 1 | 6.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ConvaTec Inc. | $4,000 | 1 | $0 (2024) |
| Imbed Biosciences Inc. | $3,508 | 45 | $0 (2023) |
| ORGANOGENESIS INC. | $1,351 | 15 | $0 (2020) |
| Pylant Medical | $808.63 | 3 | $0 (2024) |
| Sanara MedTech Inc. | $364.92 | 7 | $0 (2022) |
| Paragon 28, Inc. | $193.33 | 1 | $0 (2021) |
| Integra LifeSciences Corporation | $152.84 | 3 | $0 (2020) |
| TRIAD LIFE SCIENCES INC. | $129.61 | 1 | $0 (2022) |
| Medtronic, Inc. | $129.35 | 1 | $0 (2023) |
| Stimwave Technologies Incorporated | $112.56 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,026 | 2 | ConvaTec Inc. ($4,000) |
| 2023 | $3,545 | 46 | Imbed Biosciences Inc. ($3,390) |
| 2022 | $531.01 | 7 | TRIAD LIFE SCIENCES INC. ($129.61) |
| 2021 | $467.35 | 7 | Sanara MedTech Inc. ($242.58) |
| 2020 | $596.59 | 8 | ORGANOGENESIS INC. ($422.90) |
| 2019 | $371.66 | 7 | Organogenesis Inc. ($217.07) |
| 2018 | $1,101 | 3 | Pylant Medical ($757.00) |
| 2017 | $505.83 | 10 | Organogenesis Inc. ($422.97) |
All Payment Transactions
90 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | Pylant Medical | — | Food and Beverage | In-kind items and services | $25.94 | General |
| 06/27/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Debt forgiveness | Cash or cash equivalent | $4,000.00 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 11/02/2023 | Pylant Medical | — | Food and Beverage | In-kind items and services | $25.69 | General |
| 08/01/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $99.45 | General |
| 08/01/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $99.45 | General |
| 08/01/2023 | Imbed Biosciences Inc. | — | Food and Beverage | Cash or cash equivalent | $99.45 | General |
| 08/01/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $99.45 | General |
| 08/01/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $99.45 | General |
| 08/01/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $99.45 | General |
| 08/01/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $99.45 | General |
| 08/01/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $99.45 | General |
| 08/01/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $99.45 | General |
| 08/01/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $99.45 | General |
| 08/01/2023 | Imbed Biosciences Inc. | — | Food and Beverage | Cash or cash equivalent | $99.45 | General |
| 07/21/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $31.66 | General |
| 07/21/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $31.66 | General |
| 07/21/2023 | Imbed Biosciences Inc. | — | Food and Beverage | Cash or cash equivalent | $31.66 | General |
| 07/21/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $31.66 | General |
| 07/21/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $31.66 | General |
| 07/21/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $31.66 | General |
| 07/21/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $31.66 | General |
| 07/21/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $31.66 | General |
| 07/21/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $31.66 | General |
| 07/21/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $31.66 | General |
| 07/21/2023 | Imbed Biosciences Inc. | — | Food and Beverage | Cash or cash equivalent | $31.66 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 602 | 1,043 | $132,436 | $51,355 |
| 2022 | 16 | 672 | 1,134 | $154,340 | $59,800 |
| 2021 | 15 | 658 | 1,051 | $136,477 | $55,688 |
| 2020 | 16 | 686 | 1,099 | $123,228 | $53,886 |
Total Patients
2,618
Total Services
4,327
Medicare Billing
$220,729
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 145 | 248 | $42,304 | $17,320 | 40.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 114 | 114 | $25,542 | $9,545 | 37.4% |
| 97750 | Test or measurement for functional capacity, each 15 minutes | Office | 2023 | 61 | 190 | $12,540 | $4,310 | 34.4% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 43 | 94 | $8,460 | $3,205 | 37.9% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2023 | 17 | 40 | $6,120 | $3,135 | 51.2% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 77 | 114 | $7,524 | $3,131 | 41.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 20 | $7,907 | $2,772 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 21 | $4,750 | $1,966 | 41.4% |
| 11750 | Permanent removal fingernail or toenail | Office | 2023 | 11 | 16 | $7,168 | $1,806 | 25.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 16 | $3,328 | $1,492 | 44.8% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2023 | 19 | 22 | $2,552 | $1,220 | 47.8% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 14 | 18 | $2,142 | $754.11 | 35.2% |
| 73610 | X-ray of ankle, minimum of 3 views | Office | 2023 | 13 | 23 | $1,564 | $659.78 | 42.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 42 | $210.00 | $33.93 | 16.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 24 | 65 | $325.00 | $6.21 | 1.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 151 | 284 | $50,388 | $19,523 | 38.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 109 | 109 | $24,433 | $9,000 | 36.8% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2022 | 23 | 70 | $10,710 | $5,756 | 53.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 50 | $10,885 | $4,964 | 45.6% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 59 | 120 | $10,800 | $3,953 | 36.6% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2022 | 99 | 139 | $9,162 | $3,868 | 42.2% |
| 97750 | Test or measurement for functional capacity, each 15 minutes | Office | 2022 | 49 | 148 | $9,768 | $3,482 | 35.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 20 | $8,120 | $2,916 | 35.9% |
| 11750 | Permanent removal fingernail or toenail | Office | 2022 | 19 | 22 | $9,856 | $2,131 | 21.6% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2022 | 11 | 21 | $2,919 | $1,319 | 45.2% |
About Dr. Steven Lund, DPM
Dr. Steven Lund, DPM is a Podiatrist healthcare provider based in N Richland Hills, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184655938.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Lund, DPM has received a total of $11,145 in payments from pharmaceutical and medical device companies, with $4,026 received in 2024. These payments were reported across 90 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($6,388).
As a Medicare-enrolled provider, Lund has provided services to 2,618 Medicare beneficiaries, totaling 4,327 services with total Medicare billing of $220,729. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Podiatrist
- Location N Richland Hills, TX
- Active Since 07/06/2006
- Last Updated 04/08/2020
- Taxonomy Code 213E00000X
- Entity Type Individual
- NPI Number 1184655938
Products in Payments
- INNOVAMATRIX AC (Device) $4,130
- Puraply (Medical Supply) $422.90
- CellerateRx (Device) $364.92
- Apligraf (Biological) $287.74
- Puraply, NuShield, Affinity (Medical Supply) $217.07
- Product Portfolio (Device) $193.33
- ReNu (Biological) $160.23
- INTELLIS ADAPTIVESTIM (Device) $129.35
- ReNu/NuShield/NuCel (Biological) $121.77
- StimQ Receiver Stimulator Kit Channel A US w/Receiver (Device) $112.56
- SALTO TALARIS TOTAL ANKLE PROSTHESIS (Device) $106.43
- RAYOS (Drug) $87.54
- Affinity/NuShield (Biological) $59.19
- Peripheral Orbital Atherectomy System (Device) $56.11
- AUGMENT (Biological) $36.45
- LUZU (Drug) $33.83
- NuShield/NuCel (Biological) $33.56
- Primatrix (Device) $30.43
- NuShield (Biological) $24.33
- Affinity (Biological) $23.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.